Phase
Condition
Metabolic Disorders
Treatment
Nicotinamide Riboside (NR)
Placebo
Clinical Study ID
Ages 60-80 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Participants are able to provide signed and dated written informed consent prior toany study specific procedures
Aged ≥ 60 and ≤ 80 years
Body mass index (BMI) 25 - 35 kg/m2
Stable dietary habits (no weight loss or gain > 5 kg in the past 3 months)
No signs of active cardiovascular disease, liver or kidney malfunction
Exclusion
Exclusion Criteria:
Patients with congestive heart failure and and/or severe renal and or liverinsufficiency
Uncontrolled hypertension
Any contra-indication for MRI scanning
Alcohol consumption of > 3 servings per day for man and >2 servings per day forwoman
Smoking
Unstable body weight (weight gain or loss > 5kg in the last 3 months)
Engagement in structured exercise activities > 2 hours a week
Previous enrolment in a clinical study with an investigational product during thelast 3 months or as judged by the Investigator which would possibly hamper our studyresults
Use of food supplements containing NR or Resveratrol (similar working mechanisms)
Study Design
Connect with a study center
Finis Terrae University
Santiago, Region Metropolitana
ChileActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.